Literature DB >> 25103987

CALR versus JAK2 mutated essential thrombocythaemia - a report on 141 patients.

Adrian P Trifa1, Radu A Popp, Andrei Cucuianu, Claudia Bănescu, Mihaela Tevet, Bianca Martin, Meilin Murat, Stefan C Vesa, Delia Dima, Marcela Cândea, Mariela S Militaru, Ioan V Pop.   

Abstract

Entities:  

Keywords:  CALR; JAK2 V617F; MPL; essential thrombocythaemia; triple-negative

Mesh：

Substances：

Year:  2014        PMID： 25103987     DOI： 10.1111/bjh.13076

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  A meta-analysis comparing clinical characteristics and outcomes in CALR-mutated and JAK2V617F essential thrombocythaemia.

Authors:  Yining Yang; Xiaorui Wang; Chun Wang; Youwen Qin
Journal:  Int J Hematol       Date:  2014-12-25       Impact factor: 2.490

Review 2.  Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis.

Authors:  N Saki; R Shirzad; F Rahim; A Saki Malehi
Journal:  Clin Transl Oncol       Date:  2017-02-15       Impact factor: 3.405

3.  Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

Authors:  Stephen E Langabeer; Karl Haslam; David O'Brien; Johanna Kelly; Claire Andrews; Ciara Ryan; Richard Flavin; Patrick J Hayden; Christopher L Bacon
Journal:  Case Rep Hematol       Date:  2016-01-21

4.  Hematological relevance of JAK2 V617F and calreticulin mutations in Tunisian patients with essential thrombocythemia.

Authors:  Maroua Abdelghani; Haifa Hammami; Wiem Zidi; Hassiba Amouri; Hind Ben Hadj Othmen; Ahlem Farrah; Samia Menif
Journal:  J Clin Lab Anal       Date:  2022-06-26       Impact factor: 3.124

5.  Genetic-pathologic characterization of myeloproliferative neoplasms.

Authors:  Yonggoo Kim; Joonhong Park; Irene Jo; Gun Dong Lee; Jiyeon Kim; Ahlm Kwon; Hayoung Choi; Woori Jang; Hyojin Chae; Kyungja Han; Ki-Seong Eom; Byung-Sik Cho; Sung-Eun Lee; Jinyoung Yang; Seung-Hwan Shin; Hyunjung Kim; Yoon Ho Ko; Haeil Park; Jong Youl Jin; Seungok Lee; Dong Wook Jekarl; Seung-Ah Yahng; Myungshin Kim
Journal:  Exp Mol Med       Date:  2016-07-22       Impact factor: 8.718
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.